دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: Hemanshu Prabhakar, Indu Kapoor, Charu Mahajan سری: ISBN (شابک) : 9789811586811 ناشر: Springer سال نشر: 2020 تعداد صفحات: 0 زبان: English فرمت فایل : EPUB (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 12 مگابایت
در صورت تبدیل فایل کتاب Clinical Synopsis of COVID-19: Evolving and Challenging به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب خلاصه بالینی COVID-19: در حال تحول و چالش برانگیز نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
بیماری ویروس کرونا یا کووید-19 یا عفونت SARS-CoV-2 جدیدترین بیماری همهگیری است که انسانها را در سطح جهان تحت تأثیر قرار داده است. این بیماری به اشکال مختلف خود را نشان داده است و اکنون کانون تحقیقات در سراسر جهان است. این کتاب تمام جنبه های بالینی بیماری ویروس کرونای جدید، COVID-19، که یکی از مسری ترین بیماری هایی است که تاکنون شناخته شده است را پوشش می دهد. این شامل موضوعات مرتبط با علوم پایه، مانند ویروس شناسی و پاتوفیزیولوژی بیماری SARS-CoV-2 است. این شامل فصول مربوط به علائم بیماری و تشخیص، آماده سازی کارکنان مراقبت های بهداشتی برای مقابله با این بیماری همه گیر جهانی است. این کتاب شامل فصل هایی در مورد مدیریت بیهوشی و مراقبت های ویژه قربانیان بیماری کووید-19 است زیرا این موضوعات از اهمیت زیادی برخوردار هستند. علاوه بر این، شامل فصلی است که به جنبههای اخلاقی مسائل مطرحشده در مورد دفع اجساد قربانیان میپردازد، زیرا این بیماری همهگیر جان بسیاری را در سراسر جهان گرفته است. این شامل یک فصل در مورد ملاحظات خاص به جمعیت بیماران مانند سالمندان، اطفال و زنان باردار است. این کتاب به عنوان یک منبع مفید برای پزشکان و پزشکان در هر زمینه پزشکی عمل می کند. همچنین برای دستیاران، کارآموزان، همکارانی که دوره های خود را در پزشکی اورژانس، بیهوشی و مراقبت های ویژه و همچنین فارغ التحصیلان و حتی مقطع کارشناسی دنبال می کنند، مرتبط است. این کتاب به عنوان یک راهنمای آماده و مفید برای پزشکان از تخصص های مختلف در طول دوره بالینی آنها خواهد بود.
Corona virus disease or COVID-19 or SARS-CoV-2 infection is the latest pandemic that has affected humans globally. The disease has manifested itself in several forms and is now the focus of research worldwide. This book covers all the clinical aspects of the novel corona virus disease, COVID-19, which is one of the most contagious diseases ever known. It includes topics related to basic sciences, such as the virology and pathophysiology of the SARS-CoV-2 disease. It includes chapters related to symptomatology of the disease and making diagnosis, preparation of the health care workers to deal with this global pandemic. The book includes chapters on anesthetic and intensive care management of COVID-19 disease victims as these topics are of vast importance. Additionally, it includes a chapter giving insight in to the ethical aspects of the issues raised regarding disposal of bodies of the victims, as this pandemic has taken many lives across the world. It includes a chapter on special considerations to patient population such as geriatrics, pediatrics and pregnant women. The book serves as a useful resource for practitioners and clinicians in any field of medicine. It is also relevant for residents, trainees, fellows pursuing their courses in emergency medicine, anesthesia and critical care as well as postgraduates and even undergraduates. The book will serve as a ready-reckoner and useful guide for physicians from varied specialties during their clinical
Preface Acknowledgments Contents About the Editors 1: Introduction: History of Coronavirus Disease Pandemic References 2: Basic Virology and Pathophysiology of COVID-19 2.1 Introduction 2.2 Classification 2.3 Jump from Animals to Humans 2.4 Morphology of SARS-CoV-2 2.5 Genome of the Novel Coronavirus 2.6 Life Cycle of SARS-CoV-2 2.7 Host Immune Response 2.8 Immune Evasion by Coronaviruses 2.9 Pathogenesis 2.10 Conclusion References 3: Clinical Manifestations of Corona Virus Disease 3.1 Introduction 3.2 Clinical Manifestations of COVID-19 3.2.1 General Systemic Manifestations 3.2.2 Respiratory Manifestations 3.2.3 Neurological Manifestations 3.2.4 Cardiovascular Manifestations 3.2.5 Gastrointestinal and Hepatic Manifestations 3.2.6 Hematological and Biochemical Manifestations 3.2.7 Ophthalmic Manifestations 3.2.8 Dermatological Manifestations 3.3 Summary References 4: Diagnostic Approach to a Patient with Coronavirus Disease 4.1 Introduction 4.2 Diagnostic approach to Covid-19 4.3 Molecular Assays for Viral Nucleic Acid Detection 4.3.1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 4.3.2 Isothermal Nucleic Acid Amplification 4.3.3 Microarray-Based Hybridization Techniques 4.3.4 Amplicon-Based Metagenomic Sequencing 4.4 Serological or Immunological Assays 4.4.1 Enzyme-Linked Immunosorbent Assay (ELISA) 4.4.2 Lateral Flow Immunoassay (LFIA) 4.4.3 Luminescent Immunoassay 4.4.4 Neutralization Assay 4.4.5 Biosensor Test 4.5 Conclusion References 5: Therapeutic Approach to Coronavirus Disease 5.1 Introduction to COVID-19 Therapeutics 5.2 Antiviral Agents 5.2.1 Favipiravir 5.2.2 Remdesivir 5.2.3 Lopinavir/Ritonavir 5.2.4 Hydroxychloroquine or Chloroquine with or Without Azithromycin 5.3 Immunomodulatory Agents 5.3.1 Interleukin 6 Inhibitors 5.3.2 Corticosteroids 5.3.3 Anakinra 5.3.4 Colchicine 5.3.5 Convalescent Plasma 5.3.6 Vitamins and Minerals 5.4 Controversial Agents 5.4.1 Renin Angiotensin Aldosterone Inhibitors 5.4.2 Non-steroidal Anti-inflammatory Drugs 5.5 Summary and Future Research References 6: Anesthetic Consideration for Patients with Corona Virus Disease 6.1 Preoperative Evaluation 6.2 Operating Room Organization and Self-Protection 6.3 Airway Management 6.4 General Anesthesia 6.5 Regional Anesthesia 6.6 Fluid Management and Associated Therapy 6.7 Postoperative Management References 7: Intensive Care Management of Corona Virus Disease 7.1 Structural and Functional Features of COVID-19 ICU 7.1.1 Structural Characteristics 7.1.2 Equipment (Ventilators/Monitors/Devices) 7.1.3 Human Resources 7.2 Criteria for COVID-19 ICU Admission 7.3 Respiratory Support 7.3.1 Noninvasive Respiratory Support 7.3.2 Invasive Mechanical Ventilation 7.3.3 Prone Position 7.3.4 Extracorporeal Membrane Oxygenation (ECMO) 7.3.5 Tracheostomy 7.3.6 Lung Ultrasound 7.4 Management of Hemodynamic Failure 7.4.1 Shock 7.4.2 Fluid Therapy and Vasopressors 7.4.3 Basic and Advanced Life Support in COVID-19 Adult Patients 7.4.4 Acute Kidney Injury (AKI) and Continuous Renal Replacement Therapy (CRRT) 7.5 Adjuvant Therapies 7.5.1 Coagulation 7.5.2 Co-Infections and Antibiotics Use in COVID-19 ICU Patients 7.5.3 Steroids 7.6 Communication Strategies in the ICU at the Time of COVID-19 Pandemic 7.6.1 Basic Principles: Honesty, Punctuality, Accountability, Trust 7.6.2 Content of the Communication 7.6.3 Checklist for Communication 7.6.4 Videocalls and Other Communication Strategies 7.6.5 Communication at the End of Life and Grief References 8: Complications of Corona Virus Disease 8.1 Introduction 8.2 COVID-19-Related Pulmonary Complications 8.3 COVID-19-Related Extrapulmonary Complications 8.3.1 Hematological 8.3.2 Cardiovascular 8.3.3 Neurological 8.3.4 Renal 8.3.5 Endocrine 8.3.6 Hepatic and Gastrointestinal 8.3.7 Others (Musculoskeletal, Ophthalmological, Dermatological) 8.4 Long-Term Complications 8.4.1 Treatment-Related Complications 8.4.1.1 Medications 8.4.1.2 ICU-Related Complications 8.4.1.3 Post-ICU Discharge Syndrome 8.5 Other Possible Long-Term Complications References 9: Psychosocial Issues Related to Corona Virus Disease 9.1 Introduction 9.1.1 Psychosocial Issues Related to Corona Virus Disease 9.1.1.1 Corona Virus Disease and Effect on General Population 9.1.2 Corona Virus Disease and Healthcare Workers 9.1.3 Corona Virus Disease and Children 9.2 Signs and Symptoms 9.3 Interventions References 10: Trauma Care and Coronavirus Disease 10.1 Introduction 10.2 Epidemiology of Trauma Amidst the COVID-19 Pandemic 10.3 Trauma Care During a Pandemic 10.3.1 Prehospital Measures 10.3.2 Hospital Trauma Bay 10.3.3 COVID-19 Triage/Rule out 10.3.4 Transport of the Patient 10.4 Surgical Interventions (Fig. 10.1) 10.4.1 Blood Products 10.4.2 ICU 10.4.3 Rehabilitation and Out-Patient Services 10.5 COVID-19 in the Injured Patient 10.6 Conclusion 10.7 Summary Points References 11: Pregnant Patients and COVID-19 11.1 Introduction 11.2 Background 11.2.1 Epidemiology in the Obstetric Population 11.2.2 Patient Characteristics 11.3 COVID-19 Disease Manifestations in Pregnancy 11.4 Management of COVID-19 Disease in Pregnancy 11.4.1 Maternal Hemodynamic Goals 11.4.2 Vasopressor Choice in Pregnancy 11.4.3 ARDS Management in Pregnancy 11.4.4 Extracorporeal Life Support (ECLS)/Extracorporeal Membrane Oxygenator (ECMO) 11.4.5 Thromboembolic Disease 11.5 Antenatal Considerations 11.5.1 Fetal Monitoring and Interventions 11.5.2 Corticosteroids, Pregnancy Category B 11.5.3 Intrapartum Fever 11.5.4 Preterm Labor 11.5.5 Nutrition and Glucose Control 11.6 Timing and Mode of Delivery 11.7 Safety of Common Therapies for COVID-19 Disease in Pregnancy (Table 11.2) 11.7.1 Convalescent Plasma 11.8 Uterotonics and Postpartum Hemorrhage (PPH) 11.9 Anesthetic Management 11.9.1 Neuraxial Anesthesia 11.9.2 General Anesthesia for Cesarean Delivery 11.10 Conclusions References 12: Pediatric Patients and COVID-19 12.1 Introduction 12.2 Background 12.2.1 Epidemiology 12.2.2 Presentation of Symptoms 12.2.3 Special Considerations: Pediatric 12.2.4 Special Considerations: Neonatal 12.3 Anesthetic Consideration 12.4 Critical Care Management 12.5 Conclusion References 13: Geriatric Patients and COVID-19 13.1 Introduction 13.1.1 Background 13.2 Clinical Considerations 13.2.1 Diagnosis and Clinical Presentation 13.2.2 Frailty and COVID-19 Outcomes 13.2.3 Anesthetic Considerations 13.2.3.1 Perioperative Anesthesiologic Evaluation 13.2.3.2 General Anesthesia 13.2.3.3 Regional Anesthesia 13.2.4 Treatment 13.2.5 Recent Advances in the Treatment of Coronavirus 13.2.6 Outcomes References 14: Control of Spread of Coronavirus Disease 14.1 Transmission of Coronavirus 14.2 Infection Prevention and Control Practices in COVID-19 14.2.1 Screening and Triage 14.2.2 Source Control 14.2.3 Universal Testing 14.2.4 Engineering Controls 14.2.5 Administrative Measures 14.2.6 Patient Placement 14.2.7 Personal Protective Equipment 14.2.8 Specific Precautions for Aerosol-Generating Procedures 14.2.9 Environmental Infection Control 14.2.10 Quarantine 14.2.11 Discontinuing Infection Precautions 14.2.12 Conclusion References 15: Ethical Issues Related to Coronavirus Disease 15.1 Rights and Duties of Personnel 15.2 Allocation of Scarce Resources 15.3 Shortage of Personal Protective Equipment 15.4 End of Life and Palliative Care 15.5 Cardiopulmonary Resuscitation 15.6 Research and Data Sharing 15.7 Telemedicine 15.8 Ethical Use of Alternative Medicine 15.9 Conclusion Bibliography 16: Webliography 16.1 Society Guidelines 16.1.1 Anesthesiology 16.1.2 Cardiovascular Medicine 16.1.3 Emergency Medicine 16.1.4 Endocrinology and Diabetes 16.1.5 Gastroenterology and Hepatology 16.1.6 Infectious Diseases 16.1.7 Nephrology and Hypertension 16.1.8 Neurosciences 16.1.9 Obstetrics, Gynecology, and Women’s Health 16.1.10 Pediatrics 16.1.11 Psychiatry 16.1.12 Pulmonary and Critical Care Medicine 16.1.13 Solid Organ Transplantation 16.1.14 Surgery 16.2 International Public Health and Government Guidelines 16.3 Journals 16.4 Others